Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Go back to Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer| (NASDAQ: GENB) | Delayed: 13.07 +0.17 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.90 | 52 Week High | $ | |||
| Open | $13.04 | 52 Week Low | $ | |||
| Day High | $13.21 | P/E | N/A | |||
| Day Low | $12.80 | EPS | $ | |||
| Volume | 160,616 | |||||



